[HTML][HTML] Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine …
R Anderson - Annals of oncology, 2007 - Elsevier
Background The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-α2b (IFN) compared with dacarbazine (DTIC) in …
(HDC), interleukin-2 (IL-2) and interferon-α2b (IFN) compared with dacarbazine (DTIC) in …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha} 2b and histamine …
M Middleton, A Hauschild, D Thomson, R Anderson… - Annals of …, 2007 - elibrary.ru
RESULTS OF A MULTICENTER RANDOMIZED STUDY TO EVALUATE THE SAFETY AND
EFFICACY OF COMBINED IMMUNOTHERAPY WITH INTERLEUKIN-2, INTERFERON …
EFFICACY OF COMBINED IMMUNOTHERAPY WITH INTERLEUKIN-2, INTERFERON …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon α2b and histamine …
MR Middleton, A Hauschild, D Thomson, R Anderson… - 2007 - christie.openrepository.com
BACKGROUND: The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-alpha2b (IFN) compared with dacarbazine (DTIC) …
(HDC), interleukin-2 (IL-2) and interferon-alpha2b (IFN) compared with dacarbazine (DTIC) …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine …
M Middleton, A Hauschild, D Thomson… - Annals of …, 2007 - annalsofoncology.org
Background The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-α2b (IFN) compared with dacarbazine (DTIC) in …
(HDC), interleukin-2 (IL-2) and interferon-α2b (IFN) compared with dacarbazine (DTIC) in …
[PDF][PDF] Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine …
M Middleton, A Hauschild, D Thomson, R Anderson… - clinical …, 2007 - researchgate.net
Background: The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-a2b (IFN) compared with dacarbazine (DTIC) in …
(HDC), interleukin-2 (IL-2) and interferon-a2b (IFN) compared with dacarbazine (DTIC) in …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine …
M Middleton, A Hauschild, DB Thomson… - Annals of …, 2007 - espace.library.uq.edu.au
Background: The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-alpha 2b (IFN) compared with dacarbazine (DTIC) …
(HDC), interleukin-2 (IL-2) and interferon-alpha 2b (IFN) compared with dacarbazine (DTIC) …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha} 2b and histamine …
M Middleton, A Hauschild, D Thomson, R Anderson… - 2007 - pubmed.ncbi.nlm.nih.gov
Background The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-alpha2b (IFN) compared with dacarbazine (DTIC) …
(HDC), interleukin-2 (IL-2) and interferon-alpha2b (IFN) compared with dacarbazine (DTIC) …
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-alpha2b and histamine …
M Middleton, A Hauschild, D Thomson… - Annals of …, 2007 - diva-portal.org
Results of a multicenter randomized study to evaluate the safety and efficacy of combined
immunotherapy with interleukin-2, interferon-alpha2b and histamine dihydrochloride versus …
immunotherapy with interleukin-2, interferon-alpha2b and histamine dihydrochloride versus …
[PDF][PDF] Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine …
M Middleton, A Hauschild, D Thomson, R Anderson… - clinical trials, 2007 - academia.edu
Background: The safety and efficacy of immunotherapy with histamine dihydrochloride
(HDC), interleukin-2 (IL-2) and interferon-o2b (IFN) compared with dacarbazine (DTIC) in …
(HDC), interleukin-2 (IL-2) and interferon-o2b (IFN) compared with dacarbazine (DTIC) in …
[引用][C] Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine …
M MIDDLETON, A HAUSCHILD… - Annals of …, 2007 - pascal-francis.inist.fr
Results of a multicenter randomized study to evaluate the safety and efficacy of combined
immunotherapy with interleukin-2, interferon-a2b and histamine dihydrochloride versus …
immunotherapy with interleukin-2, interferon-a2b and histamine dihydrochloride versus …